Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

13.00
+0.08000.62%
Pre-market: 12.68-0.3200-2.46%06:31 EDT
Volume:1.34M
Turnover:17.50M
Market Cap:1.12B
PE:-3.49
High:13.59
Open:13.35
Low:12.81
Close:12.92
Loading ...
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Major Issues Report

8-K - Current report
Jan 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals